Events

Virtual Event - Psychedelics For The Treatment Of Depression: Focus On 5HT-2A The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated […]

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event - Antipsychotic Treatment Options In Schizophrenia The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, […]

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event - Psychedelics For The Treatment Of Depression: Focus On 5HT-2A The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated […]

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event - Management Of Major Depressive Disorder: Breaking Through The Barrier An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary artery disease. During this virtual event, Sanjai Rao, MD, Associate Clinical Professor and Associate Residency Training Director, University of California, San Diego, CA; […]

Virtual Event - Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry During this webinar, Dr. David Block, MD, MMM and Sucharita Somkuwar, PhD will discuss the effects of inflammation and metabolic disturbances on mood disorders in a national Virtual Event. The objectives of the presentation […]

Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses Modulation of norepinephrine (NE) has become commonplace in understanding psychiatric illnesses and in therapeutic approaches. This presentation will investigate the complex overlap of monoamines and the role of NE in neuronal circuitry. The discussion will dive deep into the relationship between local NE concentration and receptor activation, […]

Bipolar Disorder: Updates on Research and Clinical Outcomes This presentation details the multidimensional nature of bipolar disorder and highlights the wide spectrum of associated manic and depressive symptoms. The discussion will review the brain anatomical correlation of symptoms as well as the underlying pathophysiological theories. Furthermore, the impact of residual symptoms on clinical outcomes, on […]